UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.


Showing 1 comment

Please check your e-mail for a link to activate your account.
Secured Via NationBuilder
  • niall McConnell
    published this page in News 2021-10-22 10:37:39 +0100
Irish Patriots